Acumen Research and Consulting, a global provider of market research studies, recently released a report entitled “Joint Pain Injections Market (By Type: Hyaluronic Acid Injections, Corticosteroid Injections; By Joint Type: Knee And Ankle, Shoulder And Elbow, Hip Joint, Facet, Joints Of The Spine; By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026 “offers detailed insights into the market with insights into the various market segments.
The global joint pain injection market is expected to grow at a remarkable CAGR of 8% over the forecast period, reaching around $ 5.7 billion by 2026. The report provides an analysis of the global Joint Pain Injections market for the period 2015-2026, with 2019-2026 as the forecast period and 2018 as the base year.
Joint pain is the number one cause of disability in adults in the United States, according to the Arthritis Foundation. Approximately 54 million adults and 300,000 infants and children in the United States are affected by joint pain or rheumatic infections. In the US, more than 78 million people are expected to suffer from joint pain by 2040, which the specialist has analyzed. Osteoarthritis is also the most common inflammation of the joints, affecting around 31 million people in the United States. The increasing prevalence of arthritis increases the need for infection-modifying drugs that are expected to help with injections of joint pain in the specified time frame.
Download sample pages from this study @ https://www.acumenresearchandconsulting.com/request-sample/1352
Market segment analysis
In terms of injection type, joint type, end customer and district, the global injection pain market has been isolated. Regarding the injection type, corticosteroid and hyaluronic acid injections and others have been placed in the world market. Hyaluronic Acid Injections segment determines the value of the joint pain injections market. The segment is expected to be driven by the expanded recognition of caustic hyaluronic acid injections as an option as opposed to knee medical procedures. The corticosteroid segment is also expected to span the estimated time frame in a huge CAGR. As indicated by the NCBI, intra-articular corticosteroid injections are more imperative in assessing the appropriateness of corticosteroid injections as a temporary relief from discomfort.
The knee and ankle segment dominates the value market for joint pain injections. This is mainly due to the increasing incidence and prevalence of knee-related diseases worldwide. With a significant CAGR over time, the shoulder-to-coal segment is expected to expand. This is due to the widespread incidence of shoulder pain due to the increasing use of devices such as cell phones, personal computers and laptops among the population.
View the table of contents of this study @ https://www.acumenresearchandconsulting.com/joint-pain-injections-market
In terms of injection type, joint type, end customer and district, the global injection pain market has been isolated. Regarding the injection type, corticosteroid and hyaluronic acid injections and others have been placed in the world market. Hyaluronic Acid Injections segment determines the value of the joint pain injections market. The segment is expected to be driven by the expanded recognition of caustic hyaluronic injections as an option as opposed to knee medical procedures. The corticosteroid segment is also expected to span the estimated time frame in a huge CAGR. As indicated by the NCBI, intra-articular corticosteroid injections are more imperative in assessing the appropriateness of corticosteroid injections as a temporary relief from discomfort.
Based on the region, the Joint Pain Injections market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominates the global joint pain injection market, the dominance of joint-related troubling influence, an innovative turn of events, an expansion in geriatric numbers, and a solid proliferation of obesity and wellbeing in the area are due to the high recognition of visco-supplementation .
Browse the upcoming market research study @ https://www.acumenresearchandconsulting.com/forthcoming-reports
Due to the increased awareness of joint pain in agricultural nations, for example the Indian and geriatric development and the high recognition of viscombining in Japan, the market in the Asia-Pacific region is expected to grow with a significantly high CAGR during the specified period. Due to the increased awareness of joint pain, such as in India, the development of the geriatric population and the high increase in visco-supplementation in Japan, the market in the Asia-Pacific region will grow significantly in the planned period.
Allergan Plc., Pfizer Inc., Sanofi, Ferring BV, Flexion Therapeutics, Inc., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION and Chugai Pharmaceutical Co., Ltd. are major players in the Common Pain Injections market. Inc. key players expand their product portfolio by combining, acquiring and cooperating with leading medical companies that are intended to improve the availability of their products and thus stimulate the market.
Browse all current health and pharmaceutical reports on Study @ https://www.acumenresearchandconsulting.com/industry-categories/healthcare-and-pharmaceuticals
Inquiry before buying @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1352
Download this premium research study – https://www.acumenresearchandconsulting.com/buy-now/0/1352
Would you like to place an order or have a question, please contact [email protected] | +1 407 915 4157
Acumen Research and Consulting (ARC) is a global provider of market intelligence and advisory services to the information technology, investment, telecommunications, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals and executives make fact-based decisions about technology purchases and develop solid growth strategies to maintain market competition. With a team size of over 100 analysts and a collective industry experience of more than 200 years, Acumen Research and Consulting ensures that a combination of industry knowledge is provided along with global and country-specific expertise.